FIELD: chemistry.
SUBSTANCE: invention relates to the use of 3-O-sulfamate-16,16-dimethyl-D-homoequilinine as anti-oncological agent in mono- and adjuvant therapy of oncological diseases, such as hepatocarcinoma, gastric carcinoma, lung cancer, chronic myelogenous leukemia, breast cancer, including a triple negative form of breast cancer.
.
EFFECT: use of 3-O-sulfamate-16,16-dimethyl-D-homoequilinine is proposed as an anti-oncological agent that does not have uterotropic activity.
1 cl
| Title |
Year |
Author |
Number |
| 3-O-SULFAMOILOXY-6-OXA-7Β-METHYL-D-HOMO-8Α-ESTRA-1,3,5(10)-TRIEN-17Α-ONE APPLICATION FOR THE BREAST CANCER TREATMENT, INCLUDING THE TRIPLE NEGATIVE FORM, AND ITS PRODUCTION METHOD |
2018 |
- Shavva Aleksandr Grigorevich
- Morozkina Svetlana Nikolaevna
|
RU2679625C1 |
| USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM |
2018 |
- Shavva Aleksandr Grigorevich
- Morozkina Svetlana Nikolaevna
|
RU2678845C1 |
| NEW METHOD FOR SYNTHESIS OF 3-O-SULPHAMATE 16,16-DIMETHYL-D-HOMOEQUILENINE |
2021 |
- Shavva Aleksandr Grigorevich
- Morozkina Svetlana Nikolaevna
|
RU2752064C1 |
| 7β-METHYL-3,17αβ-DISULFAMOYLOXY-D-HOMO-6-OXA-ESTRA-1,3,5(10), 8,14-PENTAEN AS BREAST CANCER MCF-7 CELLS GROWTH INHIBITOR |
2016 |
- Shavva Aleksandr Grigorevich
- Morozkina Svetlana Nikolaevna
- Khotimchenko Yurij Stepanovich
|
RU2619457C1 |
| RACEMIC 2,17β-DISULFOMOYLOXY-3-METHOXY-8α-EXTRA-1,3,5(10)-TRIENE AS INHIBITOR OF TUMOUR CELL PROLIFERATION OF MCF-7 |
2014 |
- Morozkina Svetlana Nikolaevna
- Drozdov Andrej Sergeevich
- Kovalev Roman Aleksandrovich
- Filatov Mikhail Valentinovich
- Shavva Aleksandr Grigor'Evich
|
RU2562242C1 |
| MEDICINAL PREPARATION CONTAINING AROMATASE STEROID INHIBITOR FOR PROPHYLAXIS AND/OR TREATMENT OF MAMMARY CANCER |
1999 |
- Shmidt Al'Fred
- Viland Khajnrikh
|
RU2225206C2 |
| INHIBITORS OF STEROID SULFATASE |
1992 |
- Rid Majkl Dzhon
- Potter Barri Viktor Llojd
|
RU2182152C2 |
| METHOD OF TREATMENT OF LUMINAL SUBTYPE OF BREAST CANCER N1 IN POSTMENOPAUSAL PERIOD |
2016 |
- Balkanov Andrej Sergeevich
- Rozanov Ivan Dmitrievich
|
RU2624370C1 |
| DRUG BASED ON STEROID ESTROGENS FOR TREATMENT OF ENDOMETRIOSIS |
2021 |
- Shavva Aleksandr Grigorevich
- Morozkina Svetlana Nikolaevna
- Petrosyan Mariya Anatolevna
|
RU2755250C1 |
| METHOD FOR TREATMENT OF ANDROGEN RECEPTOR (AR)-POSITIVE FORMS OF BREAST CANCER USING SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARM) |
2013 |
- Dolton Dzhejms T.
- Stejner Mitchell S.
- Narayanan Ramesh
- An Suntszo
|
RU2648959C2 |
